Genital herpes causes painful sores on your genitals (sex organs). It is one of the most common sexually transmitted infections (STIs) in the U.S. It's caused by the herpes simplex virus (HSV).
News Medical on MSN16d
IgM antibodies identified as critical for fighting S. aureus infectionsStaphylococcus aureus, mostly known from its antibiotic-resistant variant Methicillin-resistant Staphylococcus aureus (MRSA), ...
Herpes is a viral infection caused by the herpes simplex virus (HSV), and it primarily comes in two forms: HSV-1 and HSV-2. HSV-1 is typically associated with oral herpes — which causes cold sor ...
IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. Now, the company has become the latest to join a hot trend in cell therapy biotech—pivoting from oncology ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
IGM Biosciences shifts focus to autoimmune disease research, cutting oncology spending and reducing its workforce. Leadership changes include the appointment of former Bristol Myers' executive ...
With CAD 236.4 billion in core AUM at the end of March 2024, IGM Financial is the largest non-bank-affiliated domestic asset manager in the Canadian market. The largest Canadian banks and ...
Der HSV hat mich in den vergangenen Jahren auf ganz unterschiedliche Weise unglaublich unterstützt. Auch deshalb stand es für mich nie zur Debatte, dass ich bei Verlängerung der Sperre auf vier ...
So muss der HSV den bis Juni 2025 gültigen Lizenzspielervertrag des Kroaten zwar kündigen, um einer Vermögensbetreuungspflicht der Kapitalgesellschaft nachzukommen und sich bei fortlaufender ...
On Tuesday, IGM Biosciences Inc. (NASDAQ:IGMS) announced a strategic pivot and pipeline transformation to accelerate and deepen its leadership in developing T cell-engaging IgM antibodies for ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback